C. Lindemalm
Impact in
- Oncology top 10%
- Cancer survivorship and care
- Viral-associated cancers and disorders
- Hematology top 10%
Papers in
- Oncology 16
- Cancer survivorship and care 6
-
- Lymphoma Diagnosis and Treatment 14
- Co-authors
- Håkan Mellstedt (13 shared papers)Peter Strang (6 shared papers)Magnus Björkholm (12 shared papers)Peter Biberfeld (13 shared papers)Leif Bergkvist (8 shared papers)Mats Lekander (4 shared papers)G. Holm (8 shared papers)B. Johansson (6 shared papers)
- Journals
- European Journal Of Haematology (4 papers)Acta Oncologica (4 papers)Cancer Immunology Immunotherapy (3 papers)Supportive Care in Cancer (3 papers)International Journal of Cancer (3 papers)
- Partner nations
- SwedenUnited StatesGermany
In The Last Decade
C. Lindemalm
39 papers receiving 790 citations
Peers
Comparison fields: 5 of 82
- Oncology 428
- Hematology 147
- Immunology 260
- Genetics 120
- Pathology and Forensic Medicine 176
Countries citing papers authored by C. Lindemalm
This map shows the geographic impact of C. Lindemalm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lindemalm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lindemalm more than expected).
Fields of papers citing papers by C. Lindemalm
This network shows the impact of papers produced by C. Lindemalm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lindemalm. The network helps show where C. Lindemalm may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Lindemalm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 82 | |
| 2 | 1982 | 79 | |
| 3 | 1988 | 69 | |
| 4 | 2007 | 65 | |
| 5 | 1988 | 42 | |
| 6 | 2005 | 35 | |
| 7 | 1990 | 35 | |
| 8 | 2011 | 34 | |
| 9 | 1989 | 32 | |
| 10 | 1983 | 32 | |
| 11 | 2012 | 31 | |
| 12 | 2012 | 31 | |
| 13 | 2008 | 26 | |
| 14 | 1988 | 22 | |
| 15 | 1983 | 20 | |
| 16 | 2007 | 17 | |
| 17 | Monocyte function in Hodgkin's disease. | 1982 | 16 |
| 18 | 1991 | 15 | |
| 19 | 1990 | 15 | |
| 20 | 1995 | 15 |
About C. Lindemalm
C. Lindemalm is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 39 papers that have together received 838 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Cancer-related cognitive impairment studies (6 papers), Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer survivorship and care (6 papers) and Acute Lymphoblastic Leukemia research (3 papers). The work is most often cited by research in Oncology (428 citations), Hematology (147 citations), Immunology (260 citations), Genetics (120 citations) and Pathology and Forensic Medicine (176 citations). C. Lindemalm has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Håkan Mellstedt, Peter Strang, Magnus Björkholm, Peter Biberfeld, Leif Bergkvist, Mats Lekander, G. Holm, B. Johansson, Birger Christensson and Jan‐Erik Frödin. Their work appears in journals such as European Journal Of Haematology, Acta Oncologica, Cancer Immunology Immunotherapy, Supportive Care in Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.